Glen Eagle Advisors, LLC Novo Nordisk A S Transaction History

Glen Eagle Advisors, LLC

$604 Billion
Q1 2025

A detailed history of Glen Eagle Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 7,319 shares of NVO stock, worth $364,339. This represents 0.08% of its overall portfolio holdings.

Number of Shares

7,319

Previous 11,468 36.18%

Holding current value

$364,339

Previous $986 Million 48.48%

% of portfolio

0.08%

Previous 0.16%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$69.3 - $90.95 $287,525 - $377,351	-4,149 Reduced 36.18%	7,319 $508 Million
Q4 2024 Feb 14, 2025	SELL	$85.0 - $120.04 $22,100 - $31,210	-260 Reduced 2.22%	11,468 $986 Million
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $131,334 - $160,398	1,103 Added 10.38%	11,728 $1.4 Billion
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $1.25 Million - $1.5 Million	10,225 Added 2556.25%	10,625 $1.52 Billion
Q1 2024 Jul 03, 2024	BUY	$102.11 - $135.92 $922,461 - $1.23 Million	9,034 New	9,034 $1.16 Billion
Q4 2023 Aug 13, 2024	SELL	$87.78 - $105.45 $327,068 - $392,906	-3,726 Reduced 32.46%	7,753 $802 Million
Q3 2023 Aug 13, 2024	BUY	$90.94 - $199.54 $935,954 - $2.05 Million	10,292 Added 867.06%	11,479 $1.04 Billion
Q2 2023 Aug 13, 2024	BUY	$155.98 - $172.65 $181,872 - $201,309	1,166 Added 5552.38%	1,187 $192 Million
Q1 2023 Aug 13, 2024	SELL	$132.34 - $159.14 $264 - $318	-2 Reduced 8.7%	21 $3.34 Million
Q4 2022 Aug 13, 2024	BUY	$102.55 - $135.33 $2,358 - $3,112	23 New	23 $3.11 Million
Q2 2022 Aug 13, 2024	SELL	$103.24 - $121.81 $1,342 - $1,583	-13 Closed	0 $0
Q1 2022 Aug 13, 2024	SELL	$93.1 - $112.54 $9,310 - $11,254	-100 Reduced 88.5%	13 $1.44 Million
Q4 2021 Aug 13, 2024	SELL	$95.88 - $117.08 $37,105 - $45,309	-387 Reduced 77.4%	113 $12.7 Million
Q4 2020 Aug 13, 2024	SELL	$63.89 - $73.8 $545,237 - $629,809	-8,534 Reduced 94.47%	500 $34.9 Million
Q3 2020 Aug 13, 2024	SELL	$63.69 - $70.22 $445 - $491	-7 Reduced 1.38%	500 $34.7 Million
Q2 2020 Aug 13, 2024	BUY	$58.54 - $67.94 $409 - $475	7 Added 1.4%	507 $33.2 Million
Q1 2020 Aug 13, 2024	BUY	$49.46 - $64.78 $1,236 - $1,619	25 Added 5.26%	500 $30.1 Million
Q4 2019 Aug 13, 2024	BUY	$49.86 - $58.26 $3,739 - $4,369	75 Added 18.75%	475 $27.5 Million
Q1 2019 Aug 13, 2024	SELL	$46.36 - $52.63 $400,272 - $454,407	-8,634 Reduced 95.57%	400 $20.9 Million
Q1 2018 Aug 14, 2024	SELL	$48.49 - $58.14 $418,662 - $501,980	-8,634 Reduced 95.57%	400 $19.7 Million
Q1 2018 Aug 13, 2024	SELL	$48.49 - $58.14 $14,547 - $17,442	-300 Reduced 42.86%	400 $19.7 Million
Q3 2017 Aug 13, 2024	SELL	$41.15 - $49.22 $342,944 - $410,199	-8,334 Reduced 92.25%	700 $33.7 Million
Q1 2017 Aug 12, 2024	BUY	N/A	300 Added 34.29%	1,175 $40.3 Million
Q4 2016 Aug 12, 2024	SELL	N/A	-8,159	875 $31.4 Million

Others Institutions Holding NVO

# of Institutions

1,744

Shares Held

337M

Call Options Held

10.7M

Put Options Held

16M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $112B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Account

Glen Eagle Advisors, LLC Novo Nordisk A S Transaction History